|
| Adding genetic scores to risk models in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.27110
Carla J. Gargallo-Puyuelo, Ángel Lanas, and María Asunción García-Gonzalez
|
| 4803-4804 |
|
| MRIbased prediction of molecular subgrouping in medulloblastoma: images speak louder than words |
|
https://doi.org/10.18632/oncotarget.27097
Archya Dasgupta, and Tejpal Gupta
|
| 4805-4807 |
|
| Dominant role of the α-chain in rejection of tumor cells bearing a specific alloantigen in TCRα transgenic mice and in in vitro experiments |
|
https://doi.org/10.18632/oncotarget.27093
Maria Zamkova, Anastasiya Kalinina, Yuliya Silaeva, Nadezhda Persiyantseva, Alexandra Bruter, Alexey Deikin, Ludmila Khromykh, and Dmitry Kazansky
|
| 4808-4821 |
|
| Combinatorial drug screening of mammary cells with induced mesenchymal transformation to identify drug combinations for triple-negative breast cancer |
|
https://doi.org/10.18632/oncotarget.27104
Sierra A. Colavito, James T. Platt, Matthew A. Held, Zongzhi Liu, Ryan Sokup, and David F. Stern
|
| 4822-4839 |
|
| Role of the P2X7 receptor in in vitro and in vivo glioma tumor growth |
|
https://doi.org/10.18632/oncotarget.27106
Letícia Scussel Bergamin, Marina Capece, Erica Salaro, Alba Clara Sarti, Simonetta Falzoni, Mery Stéfani Leivas Pereira, Marco Antônio De Bastiani, Juliete Nathali Scholl, Ana Maria O. Battastini, and Francesco Di Virgilio
|
| 4840-4856 |
|
| Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort |
|
https://doi.org/10.18632/oncotarget.27108
Tomi Akinyemiju, Justin X. Moore, Daniel Tefera Dibaba, Maria Pisu, Michael Goodman, Virginia J. Howard, Monika Safford, Susan C. Gilchrist, Mary Cushman, LeAnn Long, and Suzanne E. Judd
|
| 4857-4867 |
|
| AUF1 positively controls angiogenesis through mRNA stabilization-dependent up-regulation of HIF-1α and VEGF-A in human osteosarcoma |
|
https://doi.org/10.18632/oncotarget.27115
Huda H. Al-Khalaf, and Abdelilah Aboussekhra
|
| 4868-4879 |
|
| MicroRNA-34a/IL-6R pathway as a potential therapeutic target for ovarian high-grade serous carcinoma |
|
https://doi.org/10.18632/oncotarget.27117
Ryo Yokomizo, Nozomu Yanaihara, Noriko Yamaguchi, Misato Saito, Ayako Kawabata, Kazuaki Takahashi, Masataka Takenaka, Kyosuke Yamada, Jason Solomon Shapiro, and Aikou Okamoto
|
| 4880-4893 |
|
| Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome |
|
https://doi.org/10.18632/oncotarget.27122
Tengpeng Hu, Terkild Brink Buus, Thorbjørn Krejsgaard, Anneline Nansen, Betina Kerstin Lundholt, Pieter Spee, Simon Fredholm, David Leander Petersen, Edda Blümel, Maria Gluud, Madalena N. Monteiro, Andreas Willerslev-Olsen, Mads Hald Andersen, Per thor Straten, Özcan Met, Veronica Stolearenco, Hanne Fogh, Robert Gniadecki, Claudia Nastasi, Thomas Litman, Anders Woetmann, Lise Mette Rahbek Gjerdrum, and Niels Ødum
|
| 4894-4906 |
|
| The p21 levels have the potential to be a monitoring marker for ribociclib in breast cancer |
|
https://doi.org/10.18632/oncotarget.27127
Masafumi Iida, Misato Nakamura, Emi Tokuda, Daichi Toyosawa, Toshifumi Niwa, Noriaki Ohuchi, Takanori Ishida, and Shin-ichi Hayashi
|
| 4907-4918 |
|
| Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget |
|
https://doi.org/10.18632/oncotarget.27074
Ya-Qi Qiu, Cheng-Wei Yang, Yue-Zhi Lee, Ruey-Bing Yang, Chih-Hao Lee, Hsing-Yu Hsu, Chien-Chung Chang, and Shiow-Ju Lee
|
| 4919-4919 |
|
| Correction: Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer |
|
https://doi.org/10.18632/oncotarget.27143
Mariya Shapovalova, Julia Davydova, Christine Henzler, Mark Daniel, Scott M. Dehm, Christopher A. Warlick, and Aaron M. LeBeau
|
| 4920-4920 |
